Bank Julius Baer & Co
RCUS icon

Bank Julius Baer & Co’s Arcus Biosciences RCUS Stock Holding History

Bank Julius Baer & Co’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,000
Closed -$139K – 882
2021
Q3 		$139K Sell
4,000
-15,993
-80% -$498K ﹤0.01% 603
2021
Q2 		$549K Buy
+19,993
New +$571K ﹤0.01% 440
2021
Q1 		– Sell
-14,753
Closed -$383K – 882
2020
Q4 		$383K Sell
14,753
-11,196
-43% -$271K ﹤0.01% 490
2020
Q3 		$445K Buy
25,949
+6,699
+35% +$150K ﹤0.01% 398
2020
Q2 		$467K Sell
19,250
-19,499
-50% -$526K 0.01% 369
2020
Q1 		$538K Buy
+38,749
New +$482K 0.01% 304

Other funds holding RCUS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bank Julius Baer & Co's RCUS Position: Q4 2021 in Review

Bank Julius Baer & Co sold out of Arcus Biosciences (RCUS) in Q4 2021, closing a stake of 4,000 shares — an estimated $139K sold.

Bank Julius Baer & Co first reported a position in RCUS in Q1 2020 and held it in 6 quarters. The position peaked at $549K in Q2 2021. 142 funds tracked by Wall St. Rank hold RCUS as of Q4 2021.

  • Bank Julius Baer & Co reported no remaining Arcus Biosciences position as of Q4 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 4,000 Arcus Biosciences shares in Q4 2021, an estimated $139K.
  • Bank Julius Baer & Co first reported a position in Arcus Biosciences in Q1 2020 and held it in 6 quarters.
  • Bank Julius Baer & Co's Arcus Biosciences position peaked at $549K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2021.

Based on Bank Julius Baer & Co's 13F filing for Q4 2021, filed 15 Feb 2022.